AMN Healthcare Services Inc: Form 10-K for the period ended Dec 31, 2017
Filed with the SEC on Feb 16, 2018 and accepted by EDGAR at Feb 16, 2018, 16:02 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Cost of revenue | 12 months2017-01-01 to 2017-12-31 | $1.34bn | us-gaap:CostOfRevenue |
| Gross profit | 3 months2017-10-01 to 2017-12-31 | $162.1m | us-gaap:GrossProfit |
| Gross profit | 12 months2017-01-01 to 2017-12-31 | $644.4m | us-gaap:GrossProfit |
| Selling, general and administrative | 12 months2017-01-01 to 2017-12-31 | $399.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2017-01-01 to 2017-12-31 | $212.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2017-01-01 to 2017-12-31 | $19.7m | us-gaap:InterestExpense |
| Income tax | 12 months2017-01-01 to 2017-12-31 | $60.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2017-10-01 to 2017-12-31 | $41.2m | us-gaap:NetIncomeLoss |
| Net income | 12 months2017-01-01 to 2017-12-31 | $132.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2017-10-01 to 2017-12-31 | $0.84 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months2017-01-01 to 2017-12-31 | $2.68 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2017-10-01 to 2017-12-31 | $0.86 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months2017-01-01 to 2017-12-31 | $2.77 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2017-01-01 to 2017-12-31 | 49,430,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2017-01-01 to 2017-12-31 | $115.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2017-01-01 to 2017-12-31 | $26.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months2017-01-01 to 2017-12-31 | $20.2m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2017-12-31 | $15.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2017-12-31 | $474.2m | us-gaap:AssetsCurrent |
| Total assets | At period end2017-12-31 | $1.25bn | us-gaap:Assets |
| Current liabilities | At period end2017-12-31 | $265.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2017-12-31 | $691.4m | us-gaap:Liabilities |
| Long-term debt | At period end2017-12-31 | $319.8m | us-gaap:LongTermDebt |
| Current portion of debt | At period end2017-12-31 | $0 | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2017-12-31 | $562.5m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001142750-18-000004. Last ingested by Listed: Nov 5, 2026, 17:59 ET. Listed shows no prices and gives no investment advice.